tm
Seeing Is Believing
tm
Seeing Is Believing
APLS is currently covered by 17 analysts with an average price target of $40. This is a potential upside of $15.08 (60.51%) from yesterday's end of day stock price of $24.92.
Apellis Pharmaceuticals's activity chart (see below) currently has 408 price targets and 294 ratings on display. The stock rating distribution of APLS is 55.32% HOLD, 42.55% BUY and 2.13% SELL.
Analysts average stock forecasts to be materialized ratio is 65.41% with an average time for these price targets to be met of 199.33 days.
Highest price target for APLS is $60, Lowest price target is $18, average price target is $33.13.
Most recent stock forecast was given by SALVEEN RICHTER from GOLDMAN SACHS on 25-Sep-2025. First documented stock forecast 03-Dec-2017.
Currently out of the existing stock ratings of APLS, 26 are a HOLD (55.32%), 20 are a BUY (42.55%), 1 are a SELL (2.13%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Sell
$18
$-5.8 (-24.37%)
$32
13 days ago
(25-Sep-2025)
1/10 (10%)
$-4.37 (-19.54%)
24
Buy
$46
$22.2 (93.28%)
$41
2 months 10 days ago
(28-Jul-2025)
20/26 (76.92%)
$27.05 (142.74%)
216
Hold
$24
$0.2 (0.84%)
$23
2 months 23 days ago
(15-Jul-2025)
5/10 (50%)
$4.25 (21.52%)
29
Hold
$26
$2.2 (9.24%)
$30
3 months 7 days ago
(01-Jul-2025)
2/3 (66.67%)
$8.18 (45.90%)
23
Hold
$29
$5.2 (21.85%)
$26
4 months 7 days ago
(01-Jun-2025)
9/13 (69.23%)
$9.86 (51.52%)
110
What is APLS (Apellis Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on APLS (Apellis Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on APLS (Apellis Pharmaceuticals)?
Which analyst is the currently most bullish on APLS (Apellis Pharmaceuticals)?
Which analyst is the currently most reserved on APLS (Apellis Pharmaceuticals)?
